Cargando…
Osteoporosis /
Now in its third edition, Osteoporosis, is the most comprehensive, authoritative reference on this disease. Written by renowned experts in the field, this two-volume reference is a must-have for academic and medical libraries, physicians, researchers, and any company involved in osteoporosis researc...
| Clasificación: | Libro Electrónico |
|---|---|
| Otros Autores: | , , , , |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Amsterdam :
Elsevier/Academic Press,
2013.
|
| Edición: | Fourth edition. |
| Colección: | ClinicalKey.
|
| Temas: | |
| Acceso en línea: | Texto completo |
MARC
| LEADER | 00000cam a2200000Ii 4500 | ||
|---|---|---|---|
| 001 | SCIDIR_ocn851078242 | ||
| 003 | OCoLC | ||
| 005 | 20231117044905.0 | ||
| 006 | m o d | ||
| 007 | cr cnu---unuuu | ||
| 008 | 130627s2013 ne af ob 001 0 eng d | ||
| 040 | |a N$T |b eng |e rda |e pn |c N$T |d UIU |d YDXCP |d NEH |d CUS |d OCLCF |d OPELS |d BUF |d AU@ |d CDX |d WAU |d E7B |d OCLCO |d Q2U |d GGVRL |d KOS |d EBLCP |d IDEBK |d NJR |d OCLCQ |d S4S |d OCLCQ |d OPELS |d TMC |d COCUF |d D6H |d LOA |d ANZTR |d OCLCO |d ICA |d OCLCO |d OCLCA |d OPELS |d LVT |d OCLCO |d OCLCQ |d Z5A |d OCLCO |d MERER |d OCLCO |d OCLCQ |d ZCU |d OCLCO |d MERUC |d OCLCO |d OCLCQ |d OCLCO |d LEATE |d OCLCO |d OCLCQ |d OCLCO |d OCLCQ |d CUY |d OCLCQ |d VNS |d OCLCO |d U3W |d OCLCO |d VTS |d OCLCO |d OCLCQ |d ICG |d NLE |d OCLCO |d OCLCQ |d OCLCO |d OCLCQ |d STF |d DKC |d OCLCO |d OCLCQ |d OCLCO |d M8D |d OCLCO |d UKMGB |d UX1 |d ADU |d OCLCQ |d UAB |d OCLCO |d OCLCQ |d OCLCO | ||
| 015 | |a GBB7H8206 |2 bnb | ||
| 016 | 7 | |a 018521369 |2 Uk | |
| 019 | |a 851159792 |a 851972054 |a 855783520 |a 856624495 |a 860714901 |a 962188855 |a 972080073 |a 1058214811 |a 1063648501 |a 1101717222 |a 1112857702 |a 1141421453 |a 1162231710 |a 1224973470 |a 1241946354 |a 1259168927 | ||
| 020 | |a 9780123982520 |q (electronic bk.) | ||
| 020 | |a 0123982529 |q (electronic bk.) | ||
| 020 | |a 1299668232 |q (ebk) | ||
| 020 | |a 9781299668232 |q (ebk) | ||
| 020 | |z 9780124158535 | ||
| 020 | |z 0124158536 | ||
| 024 | 8 | |a Z99954666053 | |
| 024 | 8 | |a 99954684131 | |
| 024 | 8 | |a 99954666053 | |
| 035 | |a (OCoLC)851078242 |z (OCoLC)851159792 |z (OCoLC)851972054 |z (OCoLC)855783520 |z (OCoLC)856624495 |z (OCoLC)860714901 |z (OCoLC)962188855 |z (OCoLC)972080073 |z (OCoLC)1058214811 |z (OCoLC)1063648501 |z (OCoLC)1101717222 |z (OCoLC)1112857702 |z (OCoLC)1141421453 |z (OCoLC)1162231710 |z (OCoLC)1224973470 |z (OCoLC)1241946354 |z (OCoLC)1259168927 | ||
| 050 | 4 | |a RC931.O73 |b O75 2013 | |
| 060 | 4 | |a WE 250 |b O85113 2013 | |
| 072 | 7 | |a HEA |x 039100 |2 bisacsh | |
| 072 | 7 | |a MED |x 065000 |2 bisacsh | |
| 072 | 7 | |a MED |x 083000 |2 bisacsh | |
| 082 | 0 | 4 | |a 616.716 |2 23 |
| 245 | 0 | 0 | |a Osteoporosis / |c edited by Robert Marcus, David Feldman, David W. Dempster, Marjorie Luckey, Jane A. Cauley. |
| 250 | |a Fourth edition. | ||
| 264 | 1 | |a Amsterdam : |b Elsevier/Academic Press, |c 2013. | |
| 300 | |a 1 online resource (2 volumes (xxv, 1995 pages, 18 unnumbered pages of plates)) : |b illustrations (chiefly color) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 347 | |a text file |b PDF |2 rda | ||
| 347 | |a text file |b html |2 rda | ||
| 490 | 1 | |a ClinicalKey | |
| 500 | |a Previous edition: 2008. | ||
| 504 | |a Includes bibliographical references and index. | ||
| 505 | 0 | |a V: 1 -- The bone organ system: form and function -- The nature of osteoporosis -- Reflections on osteoporosis -- Reflections on development of concepts of intercellular communication in bone -- Osteo-odyssey: a memoir -- Development of the skeleton -- The skeletal stem cell -- Osteoclast biology -- Osteoblast biology -- Osteocyte biology -- The regulatory role of matrix protein in mineralization of bone -- Parathyroid hormone and parathyroid hormone-related protein -- Vitamin D: biology, actions, and clinical implications -- Regulation of bone cell function by estrogens -- Androgens and skeletal biology: basic mechanisms -- Phosphatonins -- Skeletal growth factors -- Wnt signaling in skeletal homeostasis and diseases -- The mechanical behavior of bone -- Cellular and molecular mechanotransduction in bone -- Adaptation of skeletal structure to mechanical loading -- Biomechanics of hip and vertebral fractures -- Prevention of osteoporosis by physical signals: defining a potential role for nondrug strategies in the treatment of musculoskeletal injury and disease -- Epidemiologic methods in studies of osteoporosis -- Genetic determinants of osteoporosis -- Race, ethnicity, and osteoporosis -- Geographic variability in hip and vertebral fractures -- Nutrition and risk for osteoporosis -- Physical activity and exercise in the maintenance of the adult skeleton and the prevention of osteoporotic fractures -- Premenopausal reproductive and hormonal characteristics and the risk for osteoporosis -- Clinical and epidemiological studies: skeletal changes across menopause -- Osteoporosis in men: epidemiology, pathophysiology, and clinical characterization -- Falls as risk factors for fracture -- Nonskeletal risk factors for osteoporosis and fractures -- Outcomes following osteoporotic fractures -- Skeletal heterogeneity and the purposes of bone remodeling: implications for the understanding of osteoporosis -- On the evolution and contemporary roles of bone remodeling -- Cytokines and the pathogenesis of osteoporosis -- Animal models for osteoporosis -- Bone and fat -- Bone mineral acquisition in utero and during infancy and childhood -- Bone acquisition in adolescence. | |
| 505 | 0 | |a V: 2 -- Osteoporosis in childhood and adolescence -- Osteoporosis associated with pregnancy -- Osteoporosis in premenopausal women -- Estrogen deficiency, postmenopausal osteoporosis, and age-related bone loss -- Immobilization osteoporosis -- Osteoporosis associated with illnesses and medications -- Glucocorticoid-induced osteoporosis -- Anticonvulsant-related bone disease -- Thyroid hormone and the skeleton -- The skeletal actions of parathyroid hormone in primary hyperparathyroidism and in osteoporosis -- Osteogenesis imperfecta and other defects of bone development as occasional causes of adult osteoporosis -- HIV and osteoporosis -- Obesity, diabetes, and fractures -- Osteoporosis in organ transplant patients -- Osteoporosis associated with rheumatologic disorders -- Osteoporosis associated with chronic kidney disease -- Oral bone loss and systemic osteoporosis: weighing the risk benefit ratio of treatment -- Cancer treatment-induced bone loss in patients with breast cancer: pathophysiology and clinical perspectives -- Pathophysiology-prostate cancer -- Mechanisms of bone destruction in myeloma -- Evaluation of the patient at risk for osteoporosis -- Imaging of osteoporosis -- Osteoporosis: who should be treated? Who should be screened? -- Clinical use of bone densitometry -- Biochemical markers of bone turnover in osteoporosis -- Fracture risk assessment: the development and application of FRAX� -- Orthopedic aspects of osteoporosis -- Falls prevention interventions -- Physical therapy, physical modalities, and exercise regimens in the management of osteoporosis -- Calcium in the treatment of osteoporosis -- Vitamin D and its metabolities and analogs in the management of osteoporosis -- Alternative therapy through nutrients and nutraceuticals -- Design considerations for clinical investigations of osteoporosis -- Lessons from bone histomorphometry on the mechanisms of action of osteoporosis drugs -- Estrogen and estrogen analogs for prevention and treatment of osteoporosis -- Androgens -- Calcitonin in osteoporosis -- Bisphosphonates: pharmacology and use in the treatment of osteoporosis -- Osteonecrosis of the jaw and atypical femoral fractures -- Condition critical: compliance and persistence with osteoporosis medications -- Denosumab for the treatment of osteoporosis -- Strontium ranelate in the prevention of osteoporotic fractures -- Parathyroid hormone treatment for osteoporosis -- New approaches to osteoporosis therapeutics -- The past, present, and uncertain future of therapeutic innovation in osteoporosis. | |
| 588 | 0 | |a Print version record. | |
| 520 | |a Now in its third edition, Osteoporosis, is the most comprehensive, authoritative reference on this disease. Written by renowned experts in the field, this two-volume reference is a must-have for academic and medical libraries, physicians, researchers, and any company involved in osteoporosis research and development. Worldwide, 200 million women between 60-80 suffer from osteoporosis and have a lifetime risk of fracture between 30 and 40 % continuing to make osteoporosis a hot topic in medicine. | ||
| 546 | |a English. | ||
| 650 | 0 | |a Osteoporosis. | |
| 650 | 2 | |a Fractures, Bone |x pathology |0 (DNLM)D050723Q000473 | |
| 650 | 2 | |a Osteoporosis |0 (DNLM)D010024 | |
| 650 | 2 | |a Osteporosis |x therapy | |
| 650 | 2 | 2 | |a Osteoporosis |x therapy |0 (DNLM)D010024Q000628 |
| 650 | 6 | |a Ost�eoporose. |0 (CaQQLa)201-0045672 | |
| 650 | 7 | |a HEALTH & FITNESS |x Diseases |x Musculoskeletal. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Orthopedics. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Rheumatology. |2 bisacsh | |
| 650 | 7 | |a Osteoporosis |2 fast |0 (OCoLC)fst01048817 | |
| 655 | 0 | |a Osteoporosis. | |
| 700 | 1 | |a Marcus, Robert, |d 1940- |e editor. | |
| 700 | 1 | |a Feldman, David, |d 1939- |e editor. | |
| 700 | 1 | |a Dempster, David W., |e editor. | |
| 700 | 1 | |a Luckey, Marjorie, |e editor. | |
| 700 | 1 | |a Cauley, Jane A., |e editor. | |
| 776 | 0 | 8 | |i Print version: |t Osteoporosis. |b Fourth edition. |d Amsterdam : Elsevier/Academic Press, 2013 |z 9780124158535 |w (OCoLC)839312872 |
| 830 | 0 | |a ClinicalKey. | |
| 856 | 4 | 0 | |u https://sciencedirect.uam.elogim.com/science/book/9780124158535 |z Texto completo |